Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- West Haven, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 75 people, planned
- Started
- 2 Apr 2025
- Expected to end
- 31 Oct 2029
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- ACT to RECOVER
- Smartphone-based Symptom-Monitoring
- Record updated
- 17 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- -For the Phase 3, Stage 1b RCT The investigators will be recruiting Veterans engaged in MOUD who also demonstrate deficits in psychosocial functioning (N = 40, n = 20 per condition)
- Eligible Veterans in must have:
- a current Opioid Use Disorder (OUD) diagnosis
- active Medication treatment for OUD (MOUD) prescription for buprenorphine or methadone
- have a Veterans Rand 12 (VR-12) Physical Component Scale (PCS) or Mental Component Scale (MCS) that is <1SD below the normed mean for their respective sex-assigned-at-birth (Selim et al., 2008)
Who cannot take part
- have untreated major psychiatric disorders (e.g., psychotic disorders)
- Participants may not:
- current (i.e., past-month) suicidal/homicidal ideation with intent (i.e., a positive C-SSRS)
- cognitive/medical impairments precluding meaningful participation (via clinician determination based on participant's behavior and/or chart review)
Where in United States
- VA Connecticut Healthcare System West Haven Campus, West Haven, CTWest Haven, United StatesContact: Noah R Wolkowicz, PhDTaking people
About the trial
What the trial wants to find out
Opioid Use Disorder (OUD) is a complex, chronic condition affecting nearly 70,000 Veterans who can experience significantly reduced quality of life (e.g., poorer social, occupational, and health-related functioning). VA clinics providing Medication treatment for OUD (MOUD); e.g., buprenorphine, methadone), the 1st-line treatment for OUD, often face challenges in also attempting to treat Veteran functional needs, which may require them to extend beyond their available resources to provide support. There is an urgent need for functionally impactful and accessible treatments for Veterans in MOUD.
Read full original descriptionShow less
Acceptance and Commitment Therapy (ACT) is a well-suited framework to support the functioning of Veterans in MOUD with over 20 years of research support. However, the traditional practice ACT requires a trained clinician to provide weekly, hour-long therapy sessions (typically for 12-16 weeks) and may be too burdensome for MOUD clinics to use alongside standard care.
Fortunately, emerging research suggests that mobile health interventions (MHIs; e.g., smartphone apps) can overcome many of these pragmatic barriers. MHIs can efficiently deliver functionally-focused treatments focused on Veteran functioning in "real-world" settings, through minimally burdensome and accessible formats. Currently however, no MHI's targeting functioning exist for Veterans in MOUD.
The proposed study will address this gap by developing and evaluating an early prototype of a targeted smartphone app designed to enhance the functional outcomes of Veterans receiving MOUD called "ACT to RECOVER" (Acceptance and Commitment Therapy to Reach Empowerment through Commitment, Openness, and Valuing Experiences in Recovery).
The study will occur in 3 phases:
Phase 1: Development. Develop content for ACT to RECOVER using Veteran (n=10) and provider feedback (n=10).
Phase 2: Iterative Usability Assessment. Conduct field testing (3 rounds, n=4-5 per round) to refine ACT to RECOVER format, acceptability, and usability.
Phase 3: Pilot ACT to RECOVER in a Stage 1b Randomized Controlled Trial (RCT). Conduct a pilot trial to compare ACT to RECOVER (n=20) to a smartphone-based symptom monitoring control group (n=20).
* (3a) Evaluate the acceptability and feasibility of each condition's app and study procedures. * (3b) Explore changes in functional (e.g., values-based living, quality of life) and clinical outcomes (e.g., illicit opioid use) which will be key outcomes in future efficacy testing.
The 2 groups in the trial
- TreatmentTreatment being tested
This Phase 3 (Stage 1b RCT) Arm will consist of n = 20 Veterans (anticipated enrollment) who will receive the prototype ACT to RECOVER smartphone intervention for 4 weeks.
Treatment: ACT to RECOVER
- ControlSham treatment, for comparison
This Phase 3 (Stage 1b RCT) Arm will consist of n = 20 Veterans (anticipated enrollment) who will be assigned to receive a smartphone-based symptom-monitoring program for 4 weeks.
Treatment: Smartphone-based Symptom-Monitoring
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Developing a Smartphone Application to Support the Functional Needs of Veterans in Medication Treatment for Opioid Use Disorder
- Record updated
- 17 August 2026